NON SMALL CELL LUNG
Clinical trials for NON SMALL CELL LUNG explained in plain language.
Never miss a new study
Get alerted when new NON SMALL CELL LUNG trials appear
Sign up with your email to follow new studies for NON SMALL CELL LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy combo shows promise in lung cancer before surgery
Disease control CompletedThis study tested whether adding the immunotherapy drug atezolizumab to standard chemotherapy before surgery helps people with stage II to IIIB non-small cell lung cancer live longer without the cancer coming back. About 453 participants received either atezolizumab plus chemo or…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
Lung cancer drug combo fails to extend survival in major trial
Disease control CompletedThis large Phase 3 trial tested whether adding aflibercept (a drug that blocks blood vessel growth) to standard chemotherapy (docetaxel) could help people with advanced non-small cell lung cancer live longer. Over 900 participants who had already tried one platinum-based treatmen…
Matched conditions: NON SMALL CELL LUNG
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 26, 2026 15:45 UTC